Abstract
For nearly 8 years, the use of 68Ga (gallium-68) PET imaging has been growing steadily, with the marketing authorisation for [68Ga]Ga-Édotréotide (Somakit®) and compassionate access to [68Ga]Ga-PSMA-11 in French nuclear medicine departments. In the very near future, the needs in 68Ga will probably be increased by commercialization of a PSMA-11 kit which will facilitate [68Ga]Ga-PSMA-11 access. 68Ga is obtained from a 68Ge (germanium-68)/68Ga (gallium-68) generator, but cyclotron production is envisaged by European medical cyclotrons. As a result, a rapid evolution of equipment and premises needed is observed. In this article, we propose to review the various stages in the use of 68Ga, from production to disposal, according to latest regulation evolutions.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
